QIM
SGYP

Quantitative Investment Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Quantitative Investment Management’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-20,600
Closed -$59K – 933
2017
Q3 		$59K Buy
+20,600
New +$70.3K ﹤0.01% 657
2017
Q1 		– Sell
-67,300
Closed -$409K – 1003
2016
Q4 		$409K Buy
+67,300
New +$352K 0.01% 712

Other funds holding SGYP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Quantitative Investment Management's SGYP Position: Q4 2017 in Review

Quantitative Investment Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2017, closing a stake of 20,600 shares — an estimated $59K sold.

Quantitative Investment Management first reported a position in SGYP in Q4 2016 and held it in 2 quarters. The position peaked at $409K in Q4 2016. 150 funds tracked by Wall St. Rank hold SGYP as of Q4 2017.

  • Quantitative Investment Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2017 after selling out during the quarter.
  • Quantitative Investment Management sold 20,600 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2017, an estimated $59K.
  • Quantitative Investment Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2016 and held it in 2 quarters.
  • Quantitative Investment Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $409K in Q4 2016.
  • 150 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2017.

Based on Quantitative Investment Management's 13F filing for Q4 2017, filed 14 Feb 2018.